JFG
RLMD icon

Jefferies Financial Group’s Relmada Therapeutics RLMD Stock Holding History

Jefferies Financial Group’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,120
Closed -$112K – 1995
2026
Q1 		$112K Sell
16,120
-5,535
-26% -$26.2K ﹤0.01% 1586
2025
Q4 		$105K Buy
+21,655
New +$72.6K ﹤0.01% 1697

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jefferies Financial Group's RLMD Position: Q2 2026 in Review

Jefferies Financial Group sold out of Relmada Therapeutics (RLMD) in Q2 2026, closing a stake of 16,120 shares — an estimated $112K sold.

Jefferies Financial Group first reported a position in RLMD in Q4 2025 and held it in 2 quarters. The position peaked at $112K in Q1 2026. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Jefferies Financial Group reported no remaining Relmada Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 16,120 Relmada Therapeutics shares in Q2 2026, an estimated $112K.
  • Jefferies Financial Group first reported a position in Relmada Therapeutics in Q4 2025 and held it in 2 quarters.
  • Jefferies Financial Group's Relmada Therapeutics position peaked at $112K in Q1 2026.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.